The efficacy of Abound on anastomotic leakage after esophagectomy
Phase 2
- Conditions
- Anastomotic leakage after esophagectomyEsophageal cancer
- Registration Number
- JPRN-jRCTs041190018
- Lead Sponsor
- Kodera Yasuhiro
- Brief Summary
The effect of treatment with Abound on the duration of treatment was explored in patients with esophageal cancer who developed anastomotic leakage after esophagectomy. No significant reduction in the duration of treatment was observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1) Age <= 20 years
2) Performance status (PS) 0-2
3) Patients who underwent esophagectomy for esophageal cancer
4) Patients who were diagnosed as an anastomotic leakage within 14 days after esophagectomy
5) Written informed consent
Exclusion Criteria
1) Severe pneumonia and sepsis
2) Leakage at the closed stump of duodenum and jejunum
3) Repeated surgery
4) Patients requiring a limiting of the water amount
5) Patients incompatible to Abound
6) Pregnancy
7) Ineligible for the study at the physician's assessment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method